Skip to main content
. 2020 Jun 26;100(10):1771–1781. doi: 10.1093/ptj/pzaa113

Table 2.

Regression Coefficients of Factors Associated With Pain Reduction at 3 and 12 Months After Interventiona

Knee OA b Hip OA b
Baseline Characteristics 3 Months B (95% CI) 12 Months B (95% CI) 3 Months B (95% CI) 12 Months B (95% CI)
Baseline pain (0–10) −0.67 (−0.69 to − 0.65) −0.70 (−0.72 to − 0.67) −0.64 (−0.67 to 0.66) −0.66 (−0.70 to − 0.63)
Age (y) 0.00 (0.00 to 0.01) 0.01 (0.01 to 0.02) n/a n/a
BMI 0.02 (0.02 to 0.03) 0.03 (0.02 to 0.04) 0.02 (0.01 to 0.03) 0.04 (0.03 to 0.06)
Sex
 Men Reference Reference Reference Reference
 Women n/a n/a 0.078 (−0.23 to 0.18) n/a
Quality of life (0–100) −0.01 (−0.01 to − 0.01) −0.01 (−0.01 to − 0.01) −0.01 (−0.01 to − 0.00) −0.01 (−0.01 to − 0.00)
Physical activity (min/wk)
  <150 Reference Reference Reference Reference
  ≥150 n/a n/a n/a −0.15 (−0.26 to − 0.04)
Living situation
 Live with someone Reference Reference Reference Reference
 Live alone n/a n/a n/a 0.12 (−0.00 to 0.24)
Education (y)
 Low (0–14) Reference Reference Reference Reference
 High (>14) −0.12 (−0.19 to − 0.05) −0.24 (−0.32 to − 0.16) −0.13 (−0.23 to − 0.02) −0.16 (−0.28 to −0.38)
Pain frequency
 Every week or less often Reference Reference Reference Reference
 Every day or all the time 0.36 (0.27 to 0.45) 0.35 (0.26 to 0.44) 0.28 (0.14 to 0.41) 0.34 (0.19 to 0.50)
Charnley class
 A (1 joint with OA) Reference Reference Reference Reference
 B (bilateral OA) 0.38 (0.30 to 0.46) 0.50 (0.34 to 0.67) 0.13 (−0.03 to 0.29) 0.10 (−0.84 to 0.28)
 C (bilateral OA + other comorbidities) 0.49 (0.41 to 0.56) 0.71 (0.56 to 0.86) 0.22 (0.11 to 0.33) 0.32 (0.20 to 0.44)
Walking difficulties due to OA
 No Reference Reference Reference Reference
 Yes n/a 0.20 (0.11 to 0.29) 0.16 (0.03 to 0.29) 0.38 (0.24 to 0.52)
Drugs for OA in last 3 mo
 No Reference Reference Reference Reference
 Yes n/a n/a n/a 0.16 (0.04 to 0.28)
Previous surgery
 No Reference Reference Reference Reference
 Yes 0.12 (0.03 to 0.20) 0.33 (0.23 to 0.42) n/a n/a
Previous surgery contralateral
 No Reference Reference Reference Reference
 Yes 0.07 (−0.29 to 0.18) 0.07 (−0.02 to 0.19) n/a n/a
Previous physical therapy
 No Reference Reference Reference Reference
 Yes 0.15 (0.08 to 0.21) 0.16 (0.09 to 0.23) 0.09 (−0.011 to 0.186) 0.16 (0.05 to 0.27)
Willingness to undergo surgery
 No Reference Reference Reference Reference
 Yes 0.36 (0.28 to 0.45) 0.51 (0.42 to 0.61) 0.50 (0.363 to 0.632) 0.50 (0.35 to 0.65)
Fear of movement
 No Reference Reference Reference Reference
 Yes −0.10 (−0.01 to − 0.03) −0.23 (−0.33 to − 0.13) n/a −0.15 (−0.31 to 0.01)
ASES pain (0–100) −0.01 (−0.01 to − 0.01) −0.01 (−0.01 to − 0.01) −0.01 (−0.013 to − 0.007) −0.01 (−0.01 to − 0.01)
ASES symptoms (0–100) −0.00 (−0.01 to 0.00) −0.00 (−0.01 to 0.00) n/a n/a

a ASES = Arthritis Self-Efficacy Scale; B = unstandardized regression coefficient; BMI = body mass index; n/a = not available due to being dropped during the backward elimination process; OA = osteoarthritis.

b

Statistically significant results are reported in bold.